Old antibiotic compounds could become life-saving drugs
Turns out, discarded antibiotic compounds could be developed for new life-saving drugs.In the heyday of antibiotic development in the mid-20th...
Turns out, discarded antibiotic compounds could be developed for new life-saving drugs.In the heyday of antibiotic development in the mid-20th...
Allergan plc , a leading global pharmaceutical company, announced that the U.S. FDA has approved Allergan's supplemental New Drug Application...
The Paris, France-based drugmaker said it is hoped that the treatment will contribute to the elimination of the disease. The...
The animal study tested whether using nanotechnology enables the exclusive delivery of the drug into the brain and causes analgesia...
The deal comes after Ablynx rejected the second acquisition proposal made by Denmark’s Novo Nordisk earlier this month for €2.5bn,...
University of Copenhagen pharmacy department assistant professor Natalja Genina said: “This technology is promising, because the medical drug can be...
There were two positive developments at Dr Reddy's that were hard to miss when the company's CFO Saumen Chakraborty and...
Researchers at the Institute of Industrial Science (IIS), the University of Tokyo, CNRS and INSERM, report a new organ-on-a-chip technology...
SMM evaluated the efficacy and safety of POMALYST/IMNOVID (pomalidomide) plus bortezomib and low-dose dexamethasone (PVd) versus bortezomib and low-dose dexamethasone...
Alexion Pharmaceuticals, Inc. announced that Judith A. Reinsdorf, J.D., has been appointed to the Company’s Board of Directors. Ms. Reinsdorf...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.